Cargando…

Hormones and COVID-19

Detalles Bibliográficos
Autores principales:	Elagizi, Andrew, Lavie, Carl J., Gersh, Felice L., O’Keefe, James H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126213/ https://www.ncbi.nlm.nih.gov/pubmed/37419577 http://dx.doi.org/10.1016/j.mayocp.2023.04.010

Ejemplares similares

COVID-19, the Female Immune Advantage, and Cardiovascular Impact
por: Gersh, Felice L., et al.
Publicado: (2021)

An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health
por: Elagizi, Andrew, et al.
Publicado: (2021)

The Human-Canine Bond: A Heart's Best Friend
por: O'Keefe, James H., et al.
Publicado: (2019)

In Reply–Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis
por: Lavie, Carl J.
Publicado: (2021)

Association of Obesity With More Critical Illness in COVID-19
por: Sharma, Abhishek, et al.
Publicado: (2020)

Takotsubo Syndrome: Cardiotoxic Stress in the COVID Era
por: O’Keefe, Evan L., et al.
Publicado: (2020)

In Reply — Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization
por: Lavie, Carl J., et al.
Publicado: (2021)

Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health
por: Rodriguez, Daniel, et al.
Publicado: (2022)

A Hunter-Gatherer Exercise Prescription to Optimize Health and Well-Being in the Modern World
por: O’Keefe, Evan L., et al.
Publicado: (2020)

Implications of obesity across the heart failure continuum
por: Elagizi, Andrew, et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients
por: Abosamak, Mohammed Fawzi, et al.
Publicado: (2021)

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Rizk, John G., et al.
Publicado: (2020)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes
por: Fares, Hassan, et al.
Publicado: (2016)

The COVID-19 pandemic and physical activity during intermittent fasting, is it safe? A call for action
por: Akbari, Hesam Addin, et al.
Publicado: (2021)

Perindopril for improving cardiovascular events
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Obesity paradox in cardiovascular disease: where do we stand?
por: Carbone, Salvatore, et al.
Publicado: (2019)

Author’s Reply: Hazardous Postoperative Outcomes of Unexpected COVID-19 Infected Patients: A Call for Global Consideration of Sampling All Asymptomatic Patients Before Surgical Treatment
por: Nahshon, Chen, et al.
Publicado: (2020)

Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19
por: Wozniak, Robert J., et al.
Publicado: (2020)

Icosapent ethyl for the treatment of severe hypertriglyceridemia
por: Fares, Hassan, et al.
Publicado: (2014)

Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report
por: Ho, Kam Sing, et al.
Publicado: (2021)

Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report
por: Ho, Kam Sing, et al.
Publicado: (2021)

Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?
por: Cagnacci, A., et al.
Publicado: (2020)

The thromboembolic risk in covid-19 women under hormonal treatment group
por: Ramírez, Isabel, et al.
Publicado: (2020)

Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients
por: Shabto, Julie M., et al.
Publicado: (2020)

Multivessel disease in STEMI patients: a perspective from limited-resource settings
por: Ahmed Ali, Ahmed Suliman, et al.
Publicado: (2018)

Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study
por: O'Keefe, James B, et al.
Publicado: (2021)

Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data
por: Lamy, Pierre-Jean, et al.
Publicado: (2020)

Characterization of Prolonged COVID-19 Symptoms in an Outpatient Telemedicine Clinic
por: Cellai, Michele, et al.
Publicado: (2020)

‘High prevalence of heterotopic ossification in critically ill patients with severe COVID-19’ – Author's reply
por: Stoira, Elisa, et al.
Publicado: (2021)

Use of a Telemedicine Risk Assessment Tool to Predict the Risk of Hospitalization of 496 Outpatients With COVID-19: Retrospective Analysis
por: O'Keefe, James B, et al.
Publicado: (2021)

Discharge characteristics and care transitions of hospitalized patients with COVID-19
por: Loerinc, Leah B., et al.
Publicado: (2021)

High prevalence of heterotopic ossification in critically ill patients with severe COVID-19
por: Stoira, Elisa, et al.
Publicado: (2021)

Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation
por: Sugimori, C, et al.
Publicado: (2012)

Reply to “Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link”
por: Elgendy, Islam Y., et al.
Publicado: (2021)

Idle medical students review emerging COVID-19 research
por: Boodman, Carl, et al.
Publicado: (2020)

Feasibility of enhanced recovery after surgery program in colorectal surgery during COVID-19 pandemic in Italy: should we change something?
por: Borghi, Felice, et al.
Publicado: (2020)

Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis
por: Franceschini, Marta, et al.
Publicado: (2020)

Operational Changes on Child and Adolescent Acute Psychiatric Treatment Programs During COVID-19
por: Waitz, Carl, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bf4mo46osi867q710d3eu0c180